Cargando…

Functional Effects of Epilepsy Associated KCNT1 Mutations Suggest Pathogenesis via Aberrant Inhibitory Neuronal Activity

KCNT1 (K(+) channel subfamily T member 1) is a sodium-activated potassium channel highly expressed in the nervous system which regulates neuronal excitability by contributing to the resting membrane potential and hyperpolarisation following a train of action potentials. Gain of function mutations in...

Descripción completa

Detalles Bibliográficos
Autores principales: Rychkov, Grigori Y., Shaukat, Zeeshan, Lim, Chiao Xin, Hussain, Rashid, Roberts, Ben J., Bonardi, Claudia M., Rubboli, Guido, Meaney, Brandon F., Whitney, Robyn, Møller, Rikke S., Ricos, Michael G., Dibbens, Leanne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740882/
https://www.ncbi.nlm.nih.gov/pubmed/36499459
http://dx.doi.org/10.3390/ijms232315133
_version_ 1784848177151606784
author Rychkov, Grigori Y.
Shaukat, Zeeshan
Lim, Chiao Xin
Hussain, Rashid
Roberts, Ben J.
Bonardi, Claudia M.
Rubboli, Guido
Meaney, Brandon F.
Whitney, Robyn
Møller, Rikke S.
Ricos, Michael G.
Dibbens, Leanne M.
author_facet Rychkov, Grigori Y.
Shaukat, Zeeshan
Lim, Chiao Xin
Hussain, Rashid
Roberts, Ben J.
Bonardi, Claudia M.
Rubboli, Guido
Meaney, Brandon F.
Whitney, Robyn
Møller, Rikke S.
Ricos, Michael G.
Dibbens, Leanne M.
author_sort Rychkov, Grigori Y.
collection PubMed
description KCNT1 (K(+) channel subfamily T member 1) is a sodium-activated potassium channel highly expressed in the nervous system which regulates neuronal excitability by contributing to the resting membrane potential and hyperpolarisation following a train of action potentials. Gain of function mutations in the KCNT1 gene are the cause of neurological disorders associated with different forms of epilepsy. To gain insights into the underlying pathobiology we investigated the functional effects of 9 recently published KCNT1 mutations, 4 previously studied KCNT1 mutations, and one previously unpublished KCNT1 variant of unknown significance. We analysed the properties of KCNT1 potassium currents and attempted to find a correlation between the changes in KCNT1 characteristics due to the mutations and severity of the neurological disorder they cause. KCNT1 mutations identified in patients with epilepsy were introduced into the full length human KCNT1 cDNA using quick-change site-directed mutagenesis protocol. Electrophysiological properties of different KCNT1 constructs were investigated using a heterologous expression system (HEK293T cells) and patch clamping. All mutations studied, except T314A, increased the amplitude of KCNT1 currents, and some mutations shifted the voltage dependence of KCNT1 open probability, increasing the proportion of channels open at the resting membrane potential. The T314A mutation did not affect KCNT1 current amplitude but abolished its voltage dependence. We observed a positive correlation between the severity of the neurological disorder and the KCNT1 channel open probability at resting membrane potential. This suggests that gain of function KCNT1 mutations cause epilepsy by increasing resting potassium conductance and suppressing the activity of inhibitory neurons. A reduction in action potential firing in inhibitory neurons due to excessively high resting potassium conductance leads to disinhibition of neural circuits, hyperexcitability and seizures.
format Online
Article
Text
id pubmed-9740882
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97408822022-12-11 Functional Effects of Epilepsy Associated KCNT1 Mutations Suggest Pathogenesis via Aberrant Inhibitory Neuronal Activity Rychkov, Grigori Y. Shaukat, Zeeshan Lim, Chiao Xin Hussain, Rashid Roberts, Ben J. Bonardi, Claudia M. Rubboli, Guido Meaney, Brandon F. Whitney, Robyn Møller, Rikke S. Ricos, Michael G. Dibbens, Leanne M. Int J Mol Sci Article KCNT1 (K(+) channel subfamily T member 1) is a sodium-activated potassium channel highly expressed in the nervous system which regulates neuronal excitability by contributing to the resting membrane potential and hyperpolarisation following a train of action potentials. Gain of function mutations in the KCNT1 gene are the cause of neurological disorders associated with different forms of epilepsy. To gain insights into the underlying pathobiology we investigated the functional effects of 9 recently published KCNT1 mutations, 4 previously studied KCNT1 mutations, and one previously unpublished KCNT1 variant of unknown significance. We analysed the properties of KCNT1 potassium currents and attempted to find a correlation between the changes in KCNT1 characteristics due to the mutations and severity of the neurological disorder they cause. KCNT1 mutations identified in patients with epilepsy were introduced into the full length human KCNT1 cDNA using quick-change site-directed mutagenesis protocol. Electrophysiological properties of different KCNT1 constructs were investigated using a heterologous expression system (HEK293T cells) and patch clamping. All mutations studied, except T314A, increased the amplitude of KCNT1 currents, and some mutations shifted the voltage dependence of KCNT1 open probability, increasing the proportion of channels open at the resting membrane potential. The T314A mutation did not affect KCNT1 current amplitude but abolished its voltage dependence. We observed a positive correlation between the severity of the neurological disorder and the KCNT1 channel open probability at resting membrane potential. This suggests that gain of function KCNT1 mutations cause epilepsy by increasing resting potassium conductance and suppressing the activity of inhibitory neurons. A reduction in action potential firing in inhibitory neurons due to excessively high resting potassium conductance leads to disinhibition of neural circuits, hyperexcitability and seizures. MDPI 2022-12-01 /pmc/articles/PMC9740882/ /pubmed/36499459 http://dx.doi.org/10.3390/ijms232315133 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Rychkov, Grigori Y.
Shaukat, Zeeshan
Lim, Chiao Xin
Hussain, Rashid
Roberts, Ben J.
Bonardi, Claudia M.
Rubboli, Guido
Meaney, Brandon F.
Whitney, Robyn
Møller, Rikke S.
Ricos, Michael G.
Dibbens, Leanne M.
Functional Effects of Epilepsy Associated KCNT1 Mutations Suggest Pathogenesis via Aberrant Inhibitory Neuronal Activity
title Functional Effects of Epilepsy Associated KCNT1 Mutations Suggest Pathogenesis via Aberrant Inhibitory Neuronal Activity
title_full Functional Effects of Epilepsy Associated KCNT1 Mutations Suggest Pathogenesis via Aberrant Inhibitory Neuronal Activity
title_fullStr Functional Effects of Epilepsy Associated KCNT1 Mutations Suggest Pathogenesis via Aberrant Inhibitory Neuronal Activity
title_full_unstemmed Functional Effects of Epilepsy Associated KCNT1 Mutations Suggest Pathogenesis via Aberrant Inhibitory Neuronal Activity
title_short Functional Effects of Epilepsy Associated KCNT1 Mutations Suggest Pathogenesis via Aberrant Inhibitory Neuronal Activity
title_sort functional effects of epilepsy associated kcnt1 mutations suggest pathogenesis via aberrant inhibitory neuronal activity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740882/
https://www.ncbi.nlm.nih.gov/pubmed/36499459
http://dx.doi.org/10.3390/ijms232315133
work_keys_str_mv AT rychkovgrigoriy functionaleffectsofepilepsyassociatedkcnt1mutationssuggestpathogenesisviaaberrantinhibitoryneuronalactivity
AT shaukatzeeshan functionaleffectsofepilepsyassociatedkcnt1mutationssuggestpathogenesisviaaberrantinhibitoryneuronalactivity
AT limchiaoxin functionaleffectsofepilepsyassociatedkcnt1mutationssuggestpathogenesisviaaberrantinhibitoryneuronalactivity
AT hussainrashid functionaleffectsofepilepsyassociatedkcnt1mutationssuggestpathogenesisviaaberrantinhibitoryneuronalactivity
AT robertsbenj functionaleffectsofepilepsyassociatedkcnt1mutationssuggestpathogenesisviaaberrantinhibitoryneuronalactivity
AT bonardiclaudiam functionaleffectsofepilepsyassociatedkcnt1mutationssuggestpathogenesisviaaberrantinhibitoryneuronalactivity
AT rubboliguido functionaleffectsofepilepsyassociatedkcnt1mutationssuggestpathogenesisviaaberrantinhibitoryneuronalactivity
AT meaneybrandonf functionaleffectsofepilepsyassociatedkcnt1mutationssuggestpathogenesisviaaberrantinhibitoryneuronalactivity
AT whitneyrobyn functionaleffectsofepilepsyassociatedkcnt1mutationssuggestpathogenesisviaaberrantinhibitoryneuronalactivity
AT møllerrikkes functionaleffectsofepilepsyassociatedkcnt1mutationssuggestpathogenesisviaaberrantinhibitoryneuronalactivity
AT ricosmichaelg functionaleffectsofepilepsyassociatedkcnt1mutationssuggestpathogenesisviaaberrantinhibitoryneuronalactivity
AT dibbensleannem functionaleffectsofepilepsyassociatedkcnt1mutationssuggestpathogenesisviaaberrantinhibitoryneuronalactivity